{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,8,30]],"date-time":"2024-08-30T08:41:52Z","timestamp":1725007312901},"reference-count":19,"publisher":"Japan Society for Clinical Immunology","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Jpn.J.clin.Immun","Jpn. J. Clin. Immunol."],"published-print":{"date-parts":[[2016]]},"DOI":"10.2177\/jsci.39.207","type":"journal-article","created":{"date-parts":[[2016,6,16]],"date-time":"2016-06-16T20:46:32Z","timestamp":1466109992000},"page":"207-212","source":"Crossref","is-referenced-by-count":3,"title":["Developing novel treatments for HTLV-1-associated myelopathy (HAM) by investigating molecular pathomechanisms"],"prefix":"10.2177","volume":"39","author":[{"given":"Natsumi","family":"ARAYA","sequence":"first","affiliation":[{"name":"Department of Advanced Medical Innovation, Institute of Medical Science, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tomoo","family":"SATO","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical Innovation, Institute of Medical Science, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ariella","family":"COLER-REILLY","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical Innovation, Institute of Medical Science, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoko","family":"YAGISHITA","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical Innovation, Institute of Medical Science, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshihisa","family":"YAMANO","sequence":"additional","affiliation":[{"name":"Department of Advanced Medical Innovation, Institute of Medical Science, St. Marianna University School of Medicine"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"972","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Osame, M., et al.: HTLV-I associated myelopathy, a new clinical entity. <i>Lancet<\/i>. <b>1<\/b>: 1031-1032, 1986.","DOI":"10.1016\/S0140-6736(86)91298-5"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Izumo, S., et al.: HTLV-I-associated myelopathy. <i>Neuropathology<\/i>. <b>20 Suppl<\/b>: S65-68, 2000.","DOI":"10.1046\/j.1440-1789.2000.00320.x"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Matsuoka, E., et al.: Perivascular T cells are infected with HTLV-I in the spinal cord lesions with HTLV-I-associated myelopathy\/tropical spastic paraparesis: double staining of immunohistochemistry and polymerase chain reaction in situ hybridization. <i>Acta Neuropathol<\/i>. <b>96<\/b>: 340-346, 1998.","DOI":"10.1007\/s004010050903"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4) Nagai, M., et al.: Analysis of HTLV-I proviral load in 202 HAM\/TSP patients and 243 asymptomatic HTLV-I carriers: high proviral load strongly predisposes to HAM\/TSP. <i>J Neurovirol<\/i>. <b>4<\/b>: 586-593, 1998.","DOI":"10.3109\/13550289809114225"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Jacobson, S.: Immunopathogenesis of human T cell lymphotropic virus type I-associated neurologic disease. <i>J Infect Dis<\/i>. <b>186 Suppl 2<\/b>: S187-192, 2002.","DOI":"10.1086\/344269"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yamano, Y., et al.: Correlation of human T-cell lymphotropic virus type 1 (HTLV-1) mRNA with proviral DNA load, virus-specific CD8(+) T cells, and disease severity in HTLV-1-associated myelopathy (HAM\/TSP). <i>Blood<\/i>. <b>99<\/b>: 88-94, 2002.","DOI":"10.1182\/blood.V99.1.88"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Saito, M., et al.: In vivo expression of the HBZ gene of HTLV-1 correlates with proviral load, inflammatory markers and disease severity in HTLV-1 associated myelopathy\/tropical spastic paraparesis (HAM\/TSP). <i>Retrovirology<\/i>. <b>6<\/b>: 19, 2009.","DOI":"10.1186\/1742-4690-6-19"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Melamed, A., et al.: Genome-wide determinants of proviral targeting, clonal abundance and expression in natural HTLV-1 infection. <i>PLoS Pathog<\/i>. <b>9<\/b>: e1003271, 2013.","DOI":"10.1371\/journal.ppat.1003271"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Zhou, X., et al.: Instability of the transcription factor Foxp3 leads to the generation of pathogenic memory T cells in vivo. <i>Nat Immunol<\/i>. <b>10<\/b>: 1000-1007, 2009.","DOI":"10.1038\/ni.1774"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Miyara, M., et al.: Functional delineation and differentiation dynamics of human CD4+ T cells expressing the FoxP3 transcription factor. <i>Immunity<\/i>. <b>30<\/b>: 899-911, 2009.","DOI":"10.1016\/j.immuni.2009.03.019"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Araya, N., et al.: HTLV-1 induces a Th1-like state in CD4+CCR4+ T cells. <i>J Clin Invest<\/i>. <b>124<\/b>: 3431-3442, 2014.","DOI":"10.1172\/JCI75250"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Yamamoto-Taguchi, N., et al.: HTLV-1 bZIP factor induces inflammation through labile Foxp3 expression. <i>PLoS Pathog<\/i>. <b>9<\/b>: e1003630, 2013.","DOI":"10.1371\/journal.ppat.1003630"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Sato, T., et al.: CSF CXCL10, CXCL9, and neopterin as candidate prognostic biomarkers for HTLV-1-associated myelopathy\/tropical spastic paraparesis. <i>PLoS Negl Trop Dis<\/i>. <b>7<\/b>: e2479, 2013.","DOI":"10.1371\/journal.pntd.0002479"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Ando, H., et al.: Positive feedback loop via astrocytes causes chronic inflammation in virus-associated myelopathy. <i>Brain<\/i>. <b>136<\/b>: 2876-2887, 2013.","DOI":"10.1093\/brain\/awt183"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Hashioka, S., et al.: Differential expression of interferon-gamma receptor on human glial cells in vivo and in vitro. <i>J Neuroimmunol<\/i>. <b>225<\/b>: 91-99, 2010.","DOI":"10.1016\/j.jneuroim.2010.04.023"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Taylor, G.P., et al.: Zidovudine plus lamivudine in Human T-Lymphotropic Virus type-I-associated myelopathy: a randomised trial. <i>Retrovirology<\/i>. <b>3<\/b>: 63, 2006.","DOI":"10.1186\/1742-4690-3-63"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Yamano, Y., et al.: Abnormally high levels of virus-infected IFN-gamma+ CCR4+ CD4+ CD25+ T cells in a retrovirus-associated neuroinflammatory disorder. <i>PLoS One<\/i>. <b>4<\/b>: e6517, 2009.","DOI":"10.1371\/journal.pone.0006517"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Yamauchi, J., et al.: Mogamulizumab, an anti-CCR4 antibody, targets human T-lymphotropic virus type 1-infected CD8+ and CD4+ T cells to treat associated myelopathy. <i>J Infect Dis<\/i>. <b>211<\/b>: 238-248, 2015.","DOI":"10.1093\/infdis\/jiu438"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Bangham, C.R., et al.: HTLV-1-associated myelopathy\/tropical spastic paraparesis. <i>Nat Rev Dis Prim<\/i>. <b>1<\/b>: 16, 2015.","DOI":"10.1038\/nrdp.2015.23"}],"container-title":["Japanese Journal of Clinical Immunology"],"original-title":["HTLV-1\u95a2\u9023\u810a\u9ac4\u75c7\uff08HAM\uff09\u306e\u5206\u5b50\u75c5\u614b\u89e3\u660e\u306b\u3088\u308b\u6cbb\u7642\u85ac\u958b\u767a\u306e\u65b0\u5c55\u958b"],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_207\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,6,24]],"date-time":"2017-06-24T12:31:56Z","timestamp":1498307516000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/jsci\/39\/3\/39_207\/_article\/-char\/ja\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.2177\/jsci.39.207","relation":{},"ISSN":["0911-4300","1349-7413"],"issn-type":[{"value":"0911-4300","type":"print"},{"value":"1349-7413","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016]]}}}